đź“‹ FDA Reference
philips integris v3000 and v4000
Philips Medical Systems
Summary: The Philips Integris V3000 and V4000 are advanced imaging systems used primarily in interventional radiology and cardiology for procedures like embolization. They are utilized by radiologists and cardiologists in hospital settings.
FDA Clearance Information
Pathway
510K
Number
K910370 ↗
Decision Date
May 28, 1991
Product Code
IZI
Device Class
Class 2
Evidence
419 studies
The Philips Integris V3000 and V4000 were cleared via the FDA 510(k) pathway on May 28, 1991. Manufactured by Philips Medical Systems, these devices are classified as Class 2 under product code IZI.
What It Is
The Philips Integris V3000 and V4000 are sophisticated imaging systems designed for high-resolution visualization during interventional procedures. They utilize advanced X-ray technology to provide real-time imaging, aiding clinicians in precise navigation and treatment delivery. These systems are integral in procedures requiring detailed vascular imaging, such as embolizations.
Clinical Applications
These devices are commonly used in interventional radiology and cardiology settings for procedures like embolization, angioplasty, and stent placements. They are essential in hospital environments where precise imaging is crucial for patient outcomes. The systems are particularly beneficial for treating conditions such as aneurysms or vascular malformations in diverse patient populations.
Indications for Use
The FDA indications for the Philips Integris V3000 and V4000 include use in procedures involving liquid embolization agents. This means they are suitable for patients requiring vascular interventions to block abnormal blood flow or to treat vascular lesions.
Practical Considerations
The Philips Integris systems are compatible with a range of catheters and embolization materials. Clinicians should be familiar with the system's interface and imaging capabilities to optimize procedural outcomes. Regular maintenance and calibration are recommended to ensure optimal performance.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is the Philips Integris V3000 and V4000 used for?
These devices are used for high-resolution imaging during interventional procedures such as embolization, angioplasty, and stent placements.
What specialties typically use this device?
Interventional radiologists and cardiologists primarily use these imaging systems in hospital settings.
What are the FDA-cleared indications?
The devices are indicated for use in procedures involving liquid embolization agents, suitable for treating vascular conditions.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.